| |
| Device | Impella Ventricular Support Systems |
| Generic Name | Temporary non-roller type left heart support blood pump |
| Applicant | Abiomed, Inc. 22 Cherry Hill Dr. Danvers, MA 01923 |
| PMA Number | P140003 |
| Supplement Number | S018 |
| Date Received | 04/03/2017 |
| Decision Date | 02/07/2018 |
| Product Code |
OZD |
| Docket Number | 18M-0620 |
| Notice Date | 02/09/2018 |
| Advisory Committee |
Cardiovascular |
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Impella Ventricular Support Systems. The device is indicated for the treatment of ongoing cardiogenic shock that occurs:1) immediately (<48 hours) following acute myocardial infarction or open heart surgery; or2) in the setting of cardiomyopathy, including peripartum cardiomyopathy, or myocarditis.As a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures.* The intent of the Impella Support Systems therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.*Optimal medical management and conventional treatment measures include volume loading and use of pressors and inotropes, with or without IABP. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |